Skip to main content
Fig. 1 | Alzheimer's Research & Therapy

Fig. 1

From: Prognostic value of plasma biomarkers for informing clinical trial design in mild-to-moderate Alzheimer’s disease

Fig. 1

Heat maps of (a) Unadjusted (lower triangle) and adjusted (partial; upper triangle) correlations between baseline plasma biomarker concentrations, baseline MRI volumetric measures, and baseline scores on the ADAS-Cog11 and CDR-SB, and (b) Unadjusted and adjusted (partial) correlations between baseline or 48-week change of plasma biomarker concentrations, with 48-week change on the ADAS-Cog11, CDR-SB, and MRI volumetric measures. * p < 0.05; ** p < 0.01; *** p < 0.005

Back to article page